Baseline Heart Rate–Corrected QT and Eligibility for Clinical Trials in Oncology
- 1 September 2003
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (17), 3378-3379
- https://doi.org/10.1200/jco.2003.99.104
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizensEuropean Heart Journal, 1998
- Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer.Journal of Clinical Oncology, 1993
- Duration of the QT interval and total and cardiovascular mortality in healthy persons (The Framingham heart study experience)The American Journal of Cardiology, 1991